← Human Trials & Peer-Reviewed Studies
Adjunctive vitamin D therapy in various diseases in children: a scenario according to standard guideline.
Plain-language guide to PMID 35525920 (2022): observational study of Vitamin D, K2, Magnesium and Zinc in 400 patients.
Key Facts
- PMID
- 35525920
- Journal
- BMC pediatrics
- Year
- 2022
- Study type
- Observational Study
- Authors
- Arshad H et al. (6 authors)
- DOI
- 10.1186/s12887-022-03297-z
What This Study Did, in Plain Language
What Was Tested
This observational study looks at Vitamin D, K2, Magnesium and Zinc.
The present study aimed to evaluate the administration of adjunctive vitamin D therapy in various diseases, its adherence to standard guideline and the effect of socioeconomic status on the consumption of vitamin D in children.
Why It Was Studied
Adherence to standard guidelines is imperative when question comes to disease management.
Who Took Part
According to the abstract, 400 patients were involved.
By PubMed's age tags, the people studied were children.
Cross sectional observational study was conducted among 400 ambulatory pediatric patients at Children's Hospital, Pakistan Institute of Medical Sciences Islamabad, from November 2017 to June 2018.
Data were collected by a self-designed structured questionnaire from the patient's medical chart.
How the Study Was Run
Adjunctive vitamin D therapy adherence was evaluated by the U.
S endocrinology clinical practice guideline of vitamin D deficiency.
The association between socioeconomic status and consumption of vitamin D was examined by chi-square.
Statistical analysis was done by SPSS version 25.
What Was Measured
PubMed files the paper under topics including Cross-Sectional Studies, Dietary Supplements, Vitamin D, Vitamin D Deficiency and Vitamins.
Author keywords: Adjunctive vitamin D therapy, Comorbidities, Guideline adherence, Socioeconomic effect and Vitamin D supplementation.
What This Means in Plain Language
This is an observational study of Vitamin D, K2, Magnesium and Zinc in 400 patients.
With several hundred people or more, it is a fairly large study for this kind of research.
Its findings take up roughly 7 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2022 (BMC pediatrics), a journal based in England.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.